BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36451994)

  • 1. Coronavirus outbreaks and infection prevention in dentistry: a narrative review.
    Kapote GR; Tharwani P; Vhatkar B; Sangrar S
    Can J Dent Hyg; 2022 Oct; 56(3):140-146. PubMed ID: 36451994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral Inactivation with Emphasis on SARS-CoV-2 Using Physical and Chemical Disinfectants.
    Fadaei A
    ScientificWorldJournal; 2021; 2021():9342748. PubMed ID: 34712107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Povidone-Iodine Use in Sinonasal and Oral Cavities: A Review of Safety in the COVID-19 Era.
    Frank S; Capriotti J; Brown SM; Tessema B
    Ear Nose Throat J; 2020 Nov; 99(9):586-593. PubMed ID: 32520599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repurposing povidone-iodine to reduce the risk of SARS-CoV-2 infection and transmission: a narrative review.
    Lim NA; Teng O; Ng CYH; Bao LXY; Tambyah PA; Quek AML; Seet RCS
    Ann Med; 2022 Dec; 54(1):1488-1499. PubMed ID: 35594333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 and Dentistry: Prevention in Dental Practice, a Literature Review.
    Villani FA; Aiuto R; Paglia L; Re D
    Int J Environ Res Public Health; 2020 Jun; 17(12):. PubMed ID: 32604906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human and novel coronavirus infections in children: a review.
    Rajapakse N; Dixit D
    Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of antiseptics for rubber dam sterilization prior to endodontic treatment.
    Jakkrawanpithak P; Powattanasuk W; Sooppapipatt N; Pudla M; Srimaneekarn N; Buranachad N; Yuma S; Supa-Amornkul S
    J Oral Sci; 2024 Jan; 66(1):5-8. PubMed ID: 37853618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Povidone-Iodine Nasal and Oral Antiseptic Preparations Against Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2).
    Pelletier JS; Tessema B; Frank S; Westover JB; Brown SM; Capriotti JA
    Ear Nose Throat J; 2021 Apr; 100(2_suppl):192S-196S. PubMed ID: 32951446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid In-Vitro Inactivation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Using Povidone-Iodine Oral Antiseptic Rinse.
    Bidra AS; Pelletier JS; Westover JB; Frank S; Brown SM; Tessema B
    J Prosthodont; 2020 Jul; 29(6):529-533. PubMed ID: 32511851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro inactivation of SARS-CoV-2 using a povidone-iodine oral rinse.
    Shet M; Westover J; Hong R; Igo D; Cataldo M; Bhaskar S
    BMC Oral Health; 2022 Feb; 22(1):47. PubMed ID: 35216566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of In Vitro Inactivation of SARS CoV-2 with Hydrogen Peroxide and Povidone-Iodine Oral Antiseptic Rinses.
    Bidra AS; Pelletier JS; Westover JB; Frank S; Brown SM; Tessema B
    J Prosthodont; 2020 Aug; 29(7):599-603. PubMed ID: 32608097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians.
    Maury A; Lyoubi A; Peiffer-Smadja N; de Broucker T; Meppiel E
    Rev Neurol (Paris); 2021; 177(1-2):51-64. PubMed ID: 33446327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the potential impact of targeted vaccination strategies against severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) outbreaks in the healthcare setting.
    Abdirizak F; Lewis R; Chowell G
    Theor Biol Med Model; 2019 Oct; 16(1):16. PubMed ID: 31587665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pivoting Dental Practice Management during the COVID-19 Pandemic-A Systematic Review.
    Mahdi SS; Ahmed Z; Allana R; Peretti A; Amenta F; Nadeem Bijle M; Seow LL; Daood U
    Medicina (Kaunas); 2020 Nov; 56(12):. PubMed ID: 33255716
    [No Abstract]   [Full Text] [Related]  

  • 15. Disinfection methods against SARS-CoV-2: a systematic review.
    Viana Martins CP; Xavier CSF; Cobrado L
    J Hosp Infect; 2022 Jan; 119():84-117. PubMed ID: 34673114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The unique features of SARS-CoV-2 transmission: Comparison with SARS-CoV, MERS-CoV and 2009 H1N1 pandemic influenza virus.
    Wu Z; Harrich D; Li Z; Hu D; Li D
    Rev Med Virol; 2021 Mar; 31(2):e2171. PubMed ID: 33350025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Air disinfection procedures in the dental office during the COVID-19 pandemic.
    Tysiąc-Miśta M; Dubiel A; Brzoza K; Burek M; Pałkiewicz K
    Med Pr; 2021 Feb; 72(1):39-48. PubMed ID: 33063773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.
    Zhang XY; Huang HJ; Zhuang DL; Nasser MI; Yang MH; Zhu P; Zhao MY
    Infect Dis Poverty; 2020 Jul; 9(1):99. PubMed ID: 32690096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro virucidal activity of Echinaforce®, an Echinacea purpurea preparation, against coronaviruses, including common cold coronavirus 229E and SARS-CoV-2.
    Signer J; Jonsdottir HR; Albrich WC; Strasser M; Züst R; Ryter S; Ackermann-Gäumann R; Lenz N; Siegrist D; Suter A; Schoop R; Engler OB
    Virol J; 2020 Sep; 17(1):136. PubMed ID: 32907596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Environmental disinfection against COVID-19 in different areas of health care facilities: a review.
    Sharafi SM; Ebrahimpour K; Nafez A
    Rev Environ Health; 2021 Jun; 36(2):193-198. PubMed ID: 32845869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.